javier pinilla-ibarz, md, phd: treatment options for patients with previously treated cll
Published 8 years ago • 180 plays • Length 1:12
Download video MP4
Download video MP3
Similar videos
-
0:54
javier pinilla-ibarz, md, phd: significance of treat to progression
-
0:59
javier pinilla-ibarz, md, phd: principle treatment options for patients with a 17p deletion
-
29:01
the evolution of hipec in the treatment of cancer
-
1:52
dr. joseph kim – surgical oncology
-
15:02
how/why to become a hematologist / oncologist | with special guest dr. vinay thomas |
-
0:45
javier pinilla-ibarz, md, phd: options to prolong survival
-
0:42
javier pinilla-ibarz, md, phd: bendamustine/rituximab therapy
-
0:47
javier pinilla-ibarz, md, phd: relapse following purine analog therapy
-
1:04
javier pinilla-ibarz, md, phd: additional chemo-immunotherapy
-
0:31
javier pinilla-ibarz, md, phd: phase iii data to support usage of bruton's tkis
-
1:15:17
an insider's look - innovations in malignant hematology research
-
0:59
kenneth shain, md, phd - malignant hematology
-
0:55
dr. pinilla-ibarz on ibrutinib's efficacy in treating high-risk patients with cll
-
0:59
javier pinilla-ibarz, md, phd: use of bruton's tyrosine kinase inhibitor
-
0:37
moffitt cancer center: malignant hematology
-
3:23
moffitt breakthroughs: malignant hematology
-
1:19:17
an insider's look: innovations in malignant hematology research
-
1:48
dr. pinilla-ibarz on the role of chemotherapy in cll
-
1:24
how ibrutinib has transformed the treatment paradigm of cll
-
0:52
dr. pinilla-ibarz discusses advancements in cml
-
1:15
jeffrey lancet, md - malignant hematology
-
50:17
live ask the experts: the latest in malignant hematology
Clip.africa.com - Privacy-policy